Skip to content
Matrix Global Advisors
Matrix Global Advisors
  • Home
  • About
  • News
  • Our Work
  • Contact
  • Home
  • About
  • News
  • Our Work
  • Contact
Nov72019

MGA’s Alex Brill on CNBC’s Squawk Box

November 7, 2019Filed Under: Interviews

MGA’s Alex Brill on CNBC’s Squawk Box

On this episode of ‘Squawk Box,’ Brill discusses Bill Gate’s reaction to Senator Elizabeth Warren’s proposed wealth tax, as well as the capital gains tax.

Watch Here

Oct182019

New Belgium Brewery’s employees think like owners. Because they are.

October 18, 2019Filed Under: News

Alex Brill was quoted in Fast Company for his research on tax policy effects on business:

“… [Brill] has found that employees in ESOPs “get better at the job, and instead of quitting as soon as they get skills, they stay and get more skills.” Companies with ESOPs require fewer managers, as AEI’s Brill discovered in his research, because workers are given more freedom and are better able to manage themselves.”

Details
Oct152019

Rising Tax Burdens for Those Earning the Most

October 15, 2019Filed Under: Op-Eds

Is the tax code sufficiently progressive? The answer depends not only on the values of the person answering the question, but it also is a surprisingly tricky empirical exercise. What counts as income and who pays the corporate tax? How should one measure households?

Details
Oct72019

Pro-family tax policy: The case of the Tax Cuts and Jobs Act

October 7, 2019Filed Under: Op-Eds

There is currently a debate among policy analysts and commentators about whether the Tax Cuts and Jobs Act of 2017 (TCJA) was “pro-family.”

Details
Sep42019

Hey World: Do Not Ban E-Cigarettes

September 4, 2019Filed Under: Op-Eds

There is a hot debate in many countries over youth use of e-cigarettes, electronic devices that deliver nicotine to consumers without the deadly tar found in the smoke from traditional cigarettes. Although nicotine is not a carcinogen, it is still bad for developing brains and should not be used by young adults or pregnant women. At the same time, e-cigarettes offer real advantages over traditional tobacco products for smokers who are otherwise unable to quit.

Details
Aug232019

Employers Could Reap Substantial Savings Through Biosimilars, But Not Without Targeted Effort

August 23, 2019Filed Under: News

“A new report from Matrix Global Advisors and the National Business Group on Health, sponsored by Boehringer Ingelheim, shows that employers could see substantial savings from biosimilars, but those savings won’t come without a concerted effort to encourage biosimilar use.”

Details
Aug192019

New MGA Paper Estimates Biosimilar Savings Opportunities for Large Employers

August 19, 2019Filed Under: Analysis

This paper estimates the savings opportunity from biosimilars in the medical benefit of a large employer-sponsored health plan, using real-world claims data. This analysis illustrates the savings potential of biosimilars in the commercial market and highlights the important role of employer-sponsored plans in promoting biosimilar utilization.

Details
Aug82019

The Economics of Biologic Drugs

August 8, 2019Filed Under: Op-Eds

The market for biologic drugs in the United States is large and growing. Total US biologic sales in 2018 is estimated to have been $125 billion, an increase of 50 percent since 2014.

Details
Aug12019

Debate Over Whether Biologics Constitute Natural Monopolies Continues

August 1, 2019Filed Under: News

“Peter B. Bach, MD, a well-known critic of high drug prices, along with Jennifer A. Ohn, MPH, Preston Atteberry, MD, and Mark Trusheim, MSc, first wrote in April that biosimilar competition is an economically inefficient way to achieve the goal of lower prices; the biosimilar environment is different than the one that exists in the generic marketplace for small-molecule drugs. These authors said, instead, that biosimilars are natural monopolies and as such need price regulation in order for them to succeed and for prices to come down.”

Details
Jul262019

MGA’s Alex Brill on CNBC’s Squawk Box

July 26, 2019Filed Under: Interviews

“I think its a solid [GDP] number. Obviously the inventory piece creates a little bit of volatility and the investment numbers are a disappointment, but not a surprise. Overall we see a strong consumers. On the Fed, I would agree with Austin. What the Fed has to do now more than ever is try to block out the political noise, focus on the data and make the best call to boost their credibility or sustain their credibility.”

Details
1
2
…34567…
8910111213141516171819
20
  • Analysis(27)
  • Books(2)
  • Events(13)
  • Interviews(33)
  • News(43)
  • Op-Eds(59)
  • Press Releases(2)
  • Testimony(18)
  • Almost-Speaker McCarthy
    November 23, 2020
  • Nursing Homes Prepare for Third COVID-19 Surge
    October 26, 2020
  • Impact of the Coronavirus Pandemic on Red, Blue, and Swing States
    October 20, 2020
  • Trump Roils Markets with Conflicting Statements on Pandemic Relief
    October 7, 2020

Website Design and Developed by DreamBig Creative